论文部分内容阅读
目的探讨参麦注射液治疗小儿恙虫病并多器官功能障碍的临床疗效。方法回顾性分析本院收治的54例恙虫病合并多器官功能障碍患儿,其中27例行常规抗生素治疗(对照组),27例在常规治疗的基础上给予参麦注射液静脉滴注(观察组),疗程7d,对疗效进行比较。结果临床治愈率:观察组治愈24例,治愈率88.1%;对照组治愈14例,治愈率51.8%;两组患者临床疗效对比差异有统计学意义(P<0.05)。结论参麦注射液对患儿损伤器官功能有良好的保护和修复作用,用于辅助抗比,差异有统计学意义(P<0.05)。参麦注射液治疗恙虫病合并多器官功能障碍患儿,疗效显著,具有临床推广价值。
Objective To investigate the clinical efficacy of Shenmai injection in treating pediatric tsutsugamushi disease and multiple organ dysfunction. Methods A total of 54 schistosomiasis patients with multiple organ dysfunction admitted to our hospital were retrospectively analyzed. Twenty-seven patients were treated with conventional antibiotics (control group) and 27 were treated with intravenous infusion of Shenmai injection on the basis of routine treatment Group), course of treatment 7d, to compare the efficacy. Results The clinical cure rate: The observation group was cured in 24 cases, the cure rate was 88.1%. The control group was cured in 14 cases, the cure rate was 51.8%. There was significant difference between the two groups in clinical curative effect (P <0.05). Conclusion Shenmai injection has a good protective and rehabilitative function on injured organ in children, which is used to assist the anti-ratio, the difference was statistically significant (P <0.05). Shenmai injection for the treatment of tsutsugamushi disease in children with multiple organ dysfunction, significant effect, with clinical value.